151751-Najiba-Chargi

338 CHAPTER 17 Appendix 7. (Continued). No trismus at t 1 n = 55 Trismus at t 1 n = 14 Univariable logistic regression analysis OR (95%CI) P value T4 9 (16) 3 (21) 2.8 (0.4-10.2) .298 HPV status Negative 15 (28) 2 (14) 1.0 Positive 38 (72) 12 (86) 2.4 (0.5-11.9) .294 Unknown 2 0 Treatment modality .272 RT 24 (44) 4 (29) 1.0 CRT (cetuximab) 9 (16) 1 (7) 0.7 (0.1-6.8) .732 CRT (cisplatin) 22 (40) 9 (64) 2.5 (0.7-9.1) .180 Pretreatment trismus No 52 (96) 10 (83) Yes 2 (4) 2 (17) 5.2 (0.7-41.4) .119 Unknown 1 2 NB: Not all percentages sum up exactly to 100% due to rounding. Abbreviations: BMI = body mass index, CI = confidence interval, CRT = chemoradiotherapy (cisplatin or cetuximab based), HPV = human papilloma virus, FOIS = functional oral intake scale, OR = odds ratio, other = soft palate, uvula, oropharyngeal wall, vallecula or pharyngeal arch, RT = radiotherapy, sarcopenia = SMM below 43.2 cm 2 /m 2 , SMM = skeletal muscle mass.